ReviewCureus2025
Congenital and Neonatal Skin Disorders: Histopathological Diagnosis and Syndromic Associations.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Congenital and neonatal skin disorders encompass a broad spectrum of conditions ranging from transient benign rashes to severe genodermatoses and multisystem syndromes. Accurate diagnosis in the newborn period is critical, as cutaneous findings may be the earliest clue to underlying genetic, infectious, or systemic diseases. A comprehensive literature review was performed, drawing from up-to-date peer-reviewed studies, landmark dermatology and pathology reviews, and authoritative texts. Key information on clinical presentation, histology, and syndromic associations was extracted and synthesized. Congenital skin disorders often reflect disruptions in embryologic development or genetic mutations in skin structural proteins. Histopathological examination remains a cornerstone of diagnosis, revealing characteristic patterns (e.g., level of blister cleavage in epidermolysis bullosa, epidermolytic hyperkeratosis in ichthyoses, and eosinophilic spongiosis in incontinentia pigmenti). Many disorders form part of broader syndromes with distinctive cutaneous and systemic features. Recent advances in immunofluorescence mapping and genetic testing have improved diagnostic precision, while emerging therapies (e.g., gene therapy) hold promise for conditions previously managed only supportively. The care of neonates with skin disorders requires a multidisciplinary approach combining clinical evaluation, histopathology, and genetic insights. Early recognition of telltale skin findings and their syndromic context can guide timely interventions, genetic counseling, and anticipatory management of associated complications. Future developments in molecular diagnostics and targeted therapies are poised to further enhance outcomes in this vulnerable patient population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.